This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 44Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
---|---|---|---|---|---|---|---|---|---|
2056 | Putrescine, spermidine, spermine, N-acetylspermine and N-acetylspermidine | Metabolite | Human | Upregulated in the plasma of liver cancer patients than lung cancer patients | Diagnostic | HCC v/s Normal | p < 0.05 | Urine and Plasma | 27517900 |
2057 | Spermine, followed by N-acetylspermidine, putrescine, cadaverine, spermidine, N-acetylspermine and N-acetylputrescine | Metabolite | Human | Upregulated in the urine of liver cancer patients than lung cancer patients | Diagnostic | HCC v/s Normal | p < 0.05 | Urine and Plasma | 27517900 |
2060 | Uracil | Metabolite | Mice | Downregulated | Potential Predictive * | Cancer v/s Normal; Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2061 | cis-Aconitate acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2062 | D-4-Phosphopantothenate | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2063 | Progesterone | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2064 | 5-Thymidylic acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2065 | 2-Phospho-d-glyceric acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2066 | Niacinamide | Metabolite | Mice | Upregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2067 | Cortisone | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2068 | Imidazoleacetic acid ribotide | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2069 | 3-Methyl-2-oxovaleric acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2070 | Pseudoephedrine | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2071 | 4-Phosphopantothenoylcysteine | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2072 | Pantetheine 4-phosphate | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2073 | Hippuric acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2074 | 3-Hydroxyanthranilic acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2075 | Glycine | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2076 | Creatine | Metabolite | Mice | Upregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2077 | Cortisol | Metabolite | Mice | Upregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2078 | Allantoic acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2079 | Pantothenic acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2080 | Creatinine | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2081 | Urea | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2082 | 5-Hydroxyindoleacetic acid | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2083 | Phytosphingosine | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.05 | Urine and Plasma | 27077962 |
2084 | Imidazoleacetic acid riboside | Metabolite | Mice | Downregulated | Potential Predictive * | Drug treated group v/s control group | p < 0.01 | Urine and Plasma | 27077962 |
2107 | Combination of S100A9 and GRN | Others | Human | Downregulated in HCC patients | Diagnostic and Prognostic | Normal vs HCC | p < 0.001 | Urine | 26675302 |
2113 | Alpha-ketoglutaric | Metabolite | Human | The concentrations of α-KG in diabetic II and liver cancer urine samples were significantly lower than those from healthy people. | Diagnostic | Normal vs cancer | p < 0.05 | Urine | 25871588 |
2114 | pyruvic acid | Metabolite | Human | The concentrations of PA in diabetic II and liver cancer urine samples were significantly lower than those from healthy people. | Diagnostic | Normal vs cancer | p < 0.05 | Urine | 25871588 |
2151 | DJ-1 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2152 | CAF-1 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2153 | HSP60 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2154 | DJ-1, CAF-1 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2155 | DJ-1, HSP60 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2156 | CAF-1, HSP60 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2157 | DJ-1, CAF-1, HSP60 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2200 | AFP, (with cut off 0.9 of AFP in serum ) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2201 | BMK, (with cut off 0.40 BMK in Urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2202 | AFP, BMK, (with cut off 1.25 of AFP in serum and 0.25 BMK in urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2203 | AFP, BMK, (with cut off 1.20 of AFP in serum and 0.27 BMK in urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2204 | AFP, BMK, (with cut off 0.90 of AFP in serum and 0.40 BMK in urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2205 | AFP, BMK, (with cut off 1.65 of AFP in serum and 0.40 BMK n urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2206 | AFP, BMK, (with cut off 0.9 of AFP in serum and 0.75 BMK in urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |